Structure Therapeutics Inc. Debt Securities, Available-for-sale, Unrealized Gain
Structure Therapeutics Inc. (GPCR) reported Debt Securities, Available-for-sale, Unrealized Gain of $4.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued
us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedGain · last filed 2023-11-17
- Structure Therapeutics Inc. debt securities, available-for-sale, unrealized gain for the quarter ending 2023-09-30 was -$13.00K.
- Structure Therapeutics Inc. debt securities, available-for-sale, unrealized gain for the quarter ending 2023-06-30 was -$278.00K.
- Structure Therapeutics Inc. debt securities, available-for-sale, unrealized gain for the quarter ending 2023-03-31 was $295.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Gain 3 month | Debt Securities, Available-for-sale, Unrealized Gain 6 month | Debt Securities, Available-for-sale, Unrealized Gain 9 month | Debt Securities, Available-for-sale, Unrealized Gain 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2023-11-17 | -$291.00K derived: sum of 2 quarters · filed 2023-11-17 | $4.00K 10-Q · filed 2023-11-17 | |
| 2023-06-30 | -$278.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2023-11-17 | $17.00K 10-Q/A · filed 2023-11-17 | ||
| 2023-03-31 | $295.00K 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | $3.00K 10-Q/A · filed 2023-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |